Episode

640-360: GLP-1s (Weight loss medications)

Podcast
Toronto Today with Greg Brady
Published
May 11, 2026
Duration seconds
674
Processing state
not_requested
Canonical source
https://pdst.fm/e/traffic.megaphone.fm/CORU8398307740.mp3
Audio
https://pdst.fm/e/traffic.megaphone.fm/CORU8398307740.mp3
JSON
/v1/public/podcasts/toronto-today-with-greg-brady-4287377/episodes/640-360-glp-1s-weight-loss-medications
Markdown
/podcast/toronto-today-with-greg-brady-4287377/640-360-glp-1s-weight-loss-medications.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/toronto-today-with-greg-brady-4287377/episodes/640-360-glp-1s-weight-loss-medications/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/toronto-today-with-greg-brady-4287377/640-360-glp-1s-weight-loss-medications.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

This week's 640-360 looks at the weight loss drugs like Ozempic & Wegovy and Greg Brady spoke to Dr. Daniel Drucker, endocrinologist based at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital and Professor of Medicine in the Division of Endocrinology at University of Toronto. Learn more about your ad choices. Visit megaphone.fm/adchoices